Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Medicinteknik |
2018-10-31 09:02:42
SoftOx Solutions AS (OSE: SOFTOX-ME), developing antimicrobial products that do not contain classical antibiotics or induce microbial resistance, aiming to prevent and treat biofilm-associated infections, either as medical device or pharmaceutical products. On the 30th November the company gained the required approvals from both Danish Medicines Agency and Ethical Committee in Copenhagen to start the company’s first-in-man clinical study of its Wound Irrigation Solution (SWIS) at Copenhagen University Hospital. The clinical trial aims to show safety, tolerability and prevention of infections in acute wounds. The study is planned to start the 9th of November and will according to protocol be finalised before mid-April 2019. Oslo, Norway, 31st of October 2018